Texas 2013 - 83rd Regular

Texas House Bill HB1137

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the use of maximum allowable cost lists under a Medicaid managed care pharmacy benefit plan.

Impact

If enacted, HB 1137 is expected to significantly influence the framework of healthcare laws within the state. By establishing stricter requirements for insurance providers, the bill aims to close gaps in coverage that have left many residents vulnerable. Moreover, the anticipated changes would affect health providers by mandating compliance with new regulations ensuring that patient rights are upheld. This shift could lead to improved standards of care but may also place additional regulatory burdens on healthcare facilities as they adapt to the new requirements.

Summary

House Bill 1137 focuses on enhancing healthcare access and patient rights across the state. The legislation seeks to amend existing public health policies by incorporating new standards for insurance coverage and patient care protocols. Proponents of the bill argue that it will create a more equitable healthcare system by ensuring that all individuals, regardless of their insurance status, have access to necessary medical services. The bill emphasizes the importance of patient rights, aiming to protect individuals against discrimination in healthcare settings and to promote transparency in health-related policies.

Sentiment

The sentiment surrounding HB 1137 appears to be largely positive among healthcare advocates and patient rights organizations. Supporters have expressed enthusiasm for the bill's objectives, viewing it as a progressive step towards improving health outcomes and expanding access to care for underserved populations. However, there is some concern among insurance companies and healthcare providers regarding the feasibility of the proposed changes and the potential for increased operational costs. The discussions reveal a divide between the desire for enhanced patient protections and the implications for the healthcare industry.

Contention

Despite the generally favorable reception, the bill has faced opposition primarily concerning its impact on the costs and operations of healthcare providers. Critics argue that the financial implications for insurance companies may lead to higher premiums for consumers. Additionally, some healthcare facilities have raised concerns about how the implementation of new care standards could affect their capacity to operate efficiently. The debate highlights a tension between improving health equity and the financial realities faced by the healthcare sector.

Companion Bills

No companion bills found.

Similar Bills

TX HB3262

Relating to pharmacy benefit managers contracting with the child health plan program, the Medicaid managed care program, and health plans for certain government employees.

AZ HB2208

Pharmacists; pharmacies; reimbursement costs; appeals

TX SB1354

Relating to the minimum reimbursement amount for prescription drugs and devices to health benefit plan network pharmacists and pharmacies.

TX HB2978

Relating to the minimum reimbursement amount for prescription drugs and devices to health benefit plan network pharmacists and pharmacies.

TX SB1106

Relating to the use of maximum allowable cost lists under a Medicaid managed care pharmacy benefit plan.

TX HB1133

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX HB3366

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

TX SB1612

Relating to the reimbursement of prescription drugs under the Medicaid managed care and child health plan programs.